Veritas Receives Listing on the XETRA(tm) (Frankfurt, Germany) Trading Venue
How Can You Build Strategic Relationships in Business?
Why High Income Doesn't Always Lead to Wealth...
“On Support” Leads 13 Algos, 9 Long: Holly Morning Huddle Report
Your Office Air is Killing You... Can This Toronto-Based Company Help?
Dr. Daniel Teper, CEO of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) sits down with Equities.com's Sasha Salama to discuss the company's major milestones and catalysts.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2016 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).